Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BJDX Bluejay Diagnostics Inc
- Stocks
- Healthcare
- NASDAQ: BJDX
Price (delayed)
$1.63
Market cap
$2.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$290.56
Enterprise value
-$493,212
Highlights
Bluejay Diagnostics's debt has decreased by 41% YoY and by 16% from the previous quarter
BJDX's net income is up by 26% year-on-year and by 6% since the previous quarter
BJDX's EPS has shrunk by 154% QoQ but it has soared by 90% YoY
BJDX's quick ratio has plunged by 55% from the previous quarter but it is up by 36% YoY
Key stats
What are the main financial stats of BJDX
Market
Valuations
Earnings
Shares outstanding
1.49M
Market cap
$2.44M
Enterprise value
-$493,212
Price to earnings (P/E)
N/A
Price to book (P/B)
0.23
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.63M
Net income
-$7.25M
EBIT
-$6.44M
EBITDA
-$6.24M
Free cash flow
-$6.98M
Per share
Balance sheet
Liquidity
EPS
-$290.56
EPS diluted
-$290.56
Free cash flow per share
-$12.6
Book value per share
$6.98
Revenue per share
$0
TBVPS
$9.53
Total assets
$5.28M
Total liabilities
$1.41M
Debt
$187,374
Equity
$3.87M
Working capital
$2.26M
Debt to equity
0.05
Current ratio
2.71
Quick ratio
2.37
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-263%
Return on equity
-322.5%
Return on invested capital
-446.9%
Return on capital employed
-162.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BJDX stock price
How has the Bluejay Diagnostics stock price performed over time
Intraday
-2.98%
1 week
-10.93%
1 month
-8.94%
1 year
-99%
YTD
-66.53%
QTD
-56.3%
Financial performance
How have Bluejay Diagnostics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.63M
Net income
-$7.25M
Gross margin
N/A
Net margin
N/A
BJDX's operating income is up by 34% year-on-year and by 8% since the previous quarter
BJDX's net income is up by 26% year-on-year and by 6% since the previous quarter
Price vs fundamentals
How does BJDX's price correlate with its fundamentals
Growth
What is Bluejay Diagnostics's growth rate over time
Valuation
What is Bluejay Diagnostics stock price valuation
P/E
N/A
P/B
0.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BJDX's EPS has shrunk by 154% QoQ but it has soared by 90% YoY
BJDX's equity is down by 33% since the previous quarter but it is up by 15% year-on-year
BJDX's P/B is 23% below its last 4 quarters average of 0.3
Efficiency
How efficient is Bluejay Diagnostics business performance
The ROA has plunged by 80% YoY but it has grown by 2.8% from the previous quarter
Bluejay Diagnostics's return on equity has decreased by 48% YoY but it has increased by 4.1% QoQ
Bluejay Diagnostics's return on invested capital has increased by 41% YoY and by 3.9% QoQ
Dividends
What is BJDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BJDX.
Financial health
How did Bluejay Diagnostics financials performed over time
Bluejay Diagnostics's current ratio has plunged by 55% from the previous quarter but it has increased by 20% YoY
BJDX's quick ratio has plunged by 55% from the previous quarter but it is up by 36% YoY
Bluejay Diagnostics's debt is 95% less than its equity
The company's debt to equity fell by 44% YoY but it rose by 25% QoQ
Bluejay Diagnostics's debt has decreased by 41% YoY and by 16% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.